Novo Nordisk A/S (NYSE:NVO)
$ 135.57 1.54 (1.15%) Market Cap: 603.92 Bil Enterprise Value: 606.48 Bil PE Ratio: 46.91 PB Ratio: 42.10 GF Score: 92/100

Q2 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript

Aug 07, 2020 / 11:00AM GMT
Release Date Price: $32.32 (+1.49%)
Operator

Hello, and welcome to the Q2 2020 Novo Nordisk A/S Earnings Presentation. (Operator Instructions)

Today, I'm pleased to present Lars Fruergaard Jørgensen. Please go ahead with your meeting.

Lars Fruergaard JÃ;rgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

¸ - /- -

Thank you very much. And I would like to start out by thanking Bank of America for organizing our virtual roadshow in London this quarter. Hopefully, we can soon get together all face-to-face. But we are pleased we have this opportunity during these difficult times.

So if we look at the slides, we will quickly go through what we presented yesterday, assuming that maybe not all, but many of you have participated in the conference call yesterday, but we'll just quickly recap the slides.

If we look, firstly, I have to remind you that we'll be making forward-looking statements, and that might not turn out to actually materialize itself. So be aware of that.

Looking at our strategic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot